- Clinical Trials
- April 2025
- 60 Pages
Global
From €1308EUR$1,500USD£1,140GBP
- Report
- November 2025
- 150 Pages
Global
From €5190EUR$5,950USD£4,520GBP
- Report
- April 2025
- 200 Pages
Global
From €2172EUR$2,490USD£1,892GBP
- Report
- January 2026
- 180 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- January 2026
- 199 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- August 2025
- 189 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- January 2026
- 181 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- January 2026
- 190 Pages
Global
From €3436EUR$3,939USD£2,992GBP
- Report
- January 2026
Global
From €4274EUR$4,900USD£3,722GBP
- Report
- June 2025
Global
From €4274EUR$4,900USD£3,722GBP
- Report
- January 2026
Global
From €4274EUR$4,900USD£3,722GBP
- Report
- July 2025
Global
From €4274EUR$4,900USD£3,722GBP
- Report
- September 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- September 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- July 2025
- 175 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- April 2025
- 250 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- February 2025
- 200 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- February 2025
- 200 Pages
Global
From €3917EUR$4,490USD£3,411GBP
- Report
- February 2026
- 374 Pages
Global
From €5103EUR$5,850USD£4,444GBP
- Report
- February 2026
- 274 Pages
Global
From €5103EUR$5,850USD£4,444GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more